Australian Semiconductors Stock News

National Australia Bank recently announced its full-year earnings for the period ended 30 September 2025, reporting net income of A$6.76 billion and declaring a fully franked final dividend of 85 cents per ordinary share, payable on 12 December 2025. A key insight is that while net interest income increased year over year, overall net income and earnings per share showed a modest decrease compared to the prior year. We will now explore how the confirmed final dividend payment influences...

Earlier this week, Whitehaven Coal Limited announced it has repurchased a total of 7,456,220 ordinary fully paid securities under its ongoing on-market buy-back program as of November 12, 2025. This share buy-back reflects management’s focus on capital management and can be interpreted as a signal of confidence in the company’s financial position. We will examine how the continued share buy-back activity may influence Whitehaven Coal’s broader investment narrative and outlook. Trump has...

In recent weeks, global markets have faced a mix of challenges, including a tech-driven sell-off in U.S. stocks and the longest federal government shutdown on record, which has weighed heavily on investor sentiment. Despite these headwinds, small-cap stocks present intriguing opportunities for investors seeking growth potential amid broader market volatility. Identifying promising small-cap stocks often involves looking at companies with strong fundamentals that can weather economic...

Xero (ASX:XRO) just released its half-year earnings, revealing a clear uptick in both revenue and net income compared to last year. Investors are watching closely. These results give a snapshot of the company’s momentum. See our latest analysis for Xero. Despite delivering robust growth in both revenue and net income, Xero’s 1-day share price return fell 9.03% following the results, extending its recent slide to a 12.39% drop over the week. While long-term investors are still ahead with an...

Recently, Ramsay Santé, the European subsidiary of Ramsay Health Care, reported that for the quarter ended September 2025, revenue rose by 2.6% and EBITDA increased by 6.5%, despite funding cuts and cost inflation challenges. This performance was largely achieved through activity growth, disciplined cost management, and the expansion of care models and facilities in France, Sweden, and Norway, aligning services to evolving patient needs. We will explore how Ramsay Santé's resilience in the...

Westpac Banking (ASX:WBC) has extended its share buyback program by a year and announced a higher ordinary dividend for the recent half, with key ex-dividend and payment dates approaching. These updates highlight management's ongoing focus on shareholder returns. See our latest analysis for Westpac Banking. Westpac Banking’s active share buyback and stronger dividend appear to be fueling renewed confidence in the stock. The 2025 year-to-date share price return stands at an impressive 21.69%...

PEXA Group Limited ( ASX:PXA ) is possibly approaching a major achievement in its business, so we would like to shine...

Key Insights Aeris Resources will host its Annual General Meeting on 21st of November CEO Willie Labuschagne's total...

Key Insights Westgold Resources to hold its Annual General Meeting on 21st of November CEO Wayne Bramwell's total...

Key Insights Regis Resources to hold its Annual General Meeting on 21st of November Salary of AU$886.4k is part of CEO...

The Australian market is facing a challenging period, with the ASX 200 futures indicating a significant drop following recent U.S. economic disruptions and domestic political shifts affecting investor sentiment. Despite these hurdles, opportunities still exist for investors willing to explore less conventional avenues such as penny stocks. Although the term 'penny stocks' might seem outdated, these smaller or newer companies can offer unique growth potential when backed by strong financials;...

Pro Medicus (ASX:PME) has made headlines by clinching three major US hospital contracts in just four months. This achievement has already tripled its contract win rate from last year and sparked fresh curiosity among investors. See our latest analysis for Pro Medicus. Despite some recent share price volatility, including a 10.98% dip over the past month, Pro Medicus is still up 24.96% on a total shareholder return basis for the past year and has delivered a remarkable 336% over three years...

Key Insights Academies Australasia Group will host its Annual General Meeting on 21st of November Total pay for CEO...

Pilbara Minerals (ASX:PLS) shares are attracting attention following a surge in lithium prices, as supply disruptions and rising demand from electric vehicles fuel optimism for major producers in the sector. See our latest analysis for Pilbara Minerals. Pilbara Minerals has enjoyed a powerful rebound lately, with a 1-month share price return of 41.6% and an even sharper 71% gain so far in 2025. Renewed optimism in lithium prices and tight supply have driven this momentum. While short-term...

Mach7 Technologies Limited's ( ASX:M7T ) price-to-sales (or "P/S") ratio of 2.3x might make it look like a strong buy...

The recent 17% drop in Findi Limited's ( ASX:FND ) stock could come as a blow to insiders who purchased AU$11.6m worth...

Howard Marks put it nicely when he said that, rather than worrying about share price volatility, 'The possibility of...

The Gumtree Australia Markets Limited ( ASX:GUM ) share price has softened a substantial 28% over the previous 30 days...

Deterra Royalties Limited recently announced that its founding Managing Director and CEO, Julian Andrews, will step down for personal reasons by the end of 2025, with Non-executive Director Jason Neal appointed as interim CEO while the executive search is underway. This leadership change comes as Deterra prepares for a key investor conference presentation, underscoring a period of transition at the top of Australia's leading mining royalty enterprise with global operations. We'll explore how...

Reece Limited ( ASX:REH ), is not the largest company out there, but it saw significant share price movement during...

Key Insights Anatara Lifesciences will host its Annual General Meeting on 20th of November CEO David Brookes' total...

While some investors are already well versed in financial metrics (hat tip), this article is for those who would like...

It's not a stretch to say that Monash IVF Group Limited's ( ASX:MVF ) price-to-sales (or "P/S") ratio of 0.9x right now...

Earlier this week, DroneShield disclosed that its CEO, chairman, and a director sold a significant number of shares, following clarification that a previously announced A$7.6 million contract win was not new business but a reissue. This combination of insider selling and contract withdrawal sparked widespread investor attention and raised questions about executive confidence and the transparency of the company's sales pipeline. We'll explore how this wave of insider share sales and contract...